Myeloma Patients With Early Relapse After Stem Cell Transplant May Benefit ... The Myeloma Beacon Results of a recent small Australian study suggest that multiple myeloma patients who relapse within 12 months of their first transplant may benefit from a second transplant with melphalan plus Velcade as the intensive therapy immediately prior to ... |
